Business Trends

Jan 01, 2004
BioPharm International
In September 2003, Sweden's biotechnology sector recorded a striking achievement. Amgen, the world's largest biotechnology company, announced plans to acquire exclusive rights to Biovitrum's small-molecule enzyme inhibitors for the treatment of metabolic diseases.
Dec 01, 2003
BioPharm International
By BioPharm International Editors
Genomics companies have taken a beating on Wall Street. Will newly developed therapies like ABthrax help the sector return?
Dec 01, 2003
BioPharm International
At its August meeting, the BioPharma Operations Excellence Consortium focused on automation and IT solutions.
Dec 01, 2003
BioPharm International
By BioPharm International Editors
As the various industry sectors expand drug discovery and development activities, there will be more direct competition as well as opportunities for collaboration.
Nov 15, 2003
BioPharm International
By BioPharm International Editors
After many starts and stops, hype and disappointment, foreign protein expression in plants is now routine and biopharmaceuticals produced in green plants will soon be with us.
Nov 01, 2003
BioPharm International
By BioPharm International Editors
In a tale of two markets, shares in biopharm companies bounce back.
Nov 01, 2003
BioPharm International
By BioPharm International Editors
UK science expertise, backed by increased government funding, has led to a thriving bioscience industry, distinguished by the energy and creativity of its entrepreneurs." These words are not mine but those of Lord David Sainsbury, the British government's science and innovation minister.
Oct 01, 2003
BioPharm International
By BioPharm International Editors
With the biotechnology industry in the early phases of commercialization, many bioprocess companies are just beginning to build and operate commercial-scale production facilities.
Aug 01, 2003
BioPharm International
BioPharm International and Tefen Ltd. have teamed up to provide you with information and tools from the BioPharma Operations Excellence Consortium.
Jul 01, 2003
BioPharm International
Biopharmaceutical manufacturers face many bioprocessing concerns including safety, flexibility, maintenance, capacity, capital investment, and process costs. Disposable products can reduce some of the burden.
native1_300x100
lorem ipsum